These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10156501)

  • 21. Eliminating innovation: how price controls limit access.
    Ingram J
    J Leg Med; 2011 Jan; 32(1):115-28. PubMed ID: 21391059
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies renew price-curb talk.
    Weissenstein E
    Mod Healthc; 1994 Feb; 24(6):17. PubMed ID: 10131519
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals. Plunder and pillage.
    Earl-Slater A
    Health Serv J; 1999 May; 109(5653):18-20. PubMed ID: 10387802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
    Levy MS
    Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel imports, price controls, and innovation.
    Reisinger M; Saurí L; Zenger H
    J Health Econ; 2019 Jul; 66():163-179. PubMed ID: 31202122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative approaches to pharmaceutical price regulation in the European Union.
    Mrazek MF
    Croat Med J; 2002 Aug; 43(4):453-61. PubMed ID: 12187524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 28. Can price and regulatory controls replace free market competition in the drug industry?
    Buc NL; Levitt GM
    Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
    [No Abstract]   [Full Text] [Related]  

  • 29. Price controls for drugs.
    Rubin PH
    J Med Assoc Ga; 1995 Mar; 84(3):135-6. PubMed ID: 7738447
    [No Abstract]   [Full Text] [Related]  

  • 30. The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms.
    Zhang W; Guh D; Sun H; Marra CA; Lynd LD; Anis AH
    Med Care; 2016 Sep; 54(9):884-90. PubMed ID: 27213540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical pricing, price controls, and their effects on pharmaceutical sales and research and development expenditures in the European Union.
    Vogel RJ
    Clin Ther; 2004 Aug; 26(8):1327-40; discussion 1326. PubMed ID: 15476914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Government commitment and regulation of prescription drugs.
    Frank RG
    Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financial effects of pharmaceutical price regulation on R&D spending by EU versus US firms.
    Golec J; Vernon JA
    Pharmacoeconomics; 2010; 28(8):615-28. PubMed ID: 20617857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitigating regulatory impact: the case of partial price controls on metformin in India.
    Bhaskarabhatla A; Chatterjee C; Anurag P; Pennings E
    Health Policy Plan; 2017 Mar; 32(2):194-204. PubMed ID: 28207048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Getting to the Root of High Prescription Drug Prices.
    Waxman H; Corr B; Martin K; Duong S
    Issue Brief (Commonw Fund); 2017 Jul; 2017():1-10. PubMed ID: 28700190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. States form coalitions to leverage lower prescription drug prices.
    Young D
    Am J Health Syst Pharm; 2002 Jan; 59(1):20-1. PubMed ID: 11813461
    [No Abstract]   [Full Text] [Related]  

  • 38. Doughnut holes and price controls.
    Anderson GF; Shea DG; Hussey PS; Keyhani S; Zephyrin L
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-396-404. PubMed ID: 15451953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.
    Greene JA; Padula WV
    N Engl J Med; 2017 Jul; 377(2):101-103. PubMed ID: 28591520
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price.
    Atella V
    Health Policy; 2000 Jan; 50(3):197-218. PubMed ID: 10827308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.